In addition to our assistance of multinational companies, our attorneys and regulatory advisors have assisted many public companies traded on exchanges in the US, Canada and Australia. We understand the special nature of publicly traded companies, including the additional transparency, regulatory scrutiny, and securities filing obligations of public companies. We regularly work with foreign associates and securities and tax co-counsel to help achieve our clients' goals.
Members of our firm have assisted with the review and preparation of the intellectual property and clinical regulatory provisions in annual and quarterly filings of forms 10-K, 10-Q and 8-K. We have specifically reviewed the intellectual property and clinical regulatory provisions to make sure they are in compliance with laws and regulations.
We have also helped review, prepare and conduct due diligence with respect to intellectual property and clinical regulatory provisions on initial public offering documents including the S-1 registration statement in both initial and follow-on offerings.
Our substantial experience with public companies has also included:
Our network of trusted co-counsel assists our clients with compliance with the Securities Act of 1933 (“Securities Act”), compliance with the registration and reporting requirements of the Securities Exchange Act of 1934 (“Exchange Act”), and state corporate and securities laws compliance, and assisting in the drafting and review of Private Placement Memorandums (PPMs) for start-up companies. Foreign associates assist our clients with compliance with securities, exchange, and other public company obligations in their individual jurisdictions.
Our US co-counsel assist our clients with compliance with corporate and securities laws including:
For information on these and other legal, regulatory, and business matters, please contact us.